NCT06668389
- Conditions
- Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +10 more
- Locations
-
- Department of Medicine, Queen Mary Hospital Hong Kong
Clinical trial condition
Sodium-glucose Cotransporter 2 (SGLT2) Inhibitor
Explore clinical trials studying Sodium-glucose Cotransporter 2 (SGLT2) Inhibitor. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study